World What we know about the South African coronavirus variant
Michigan detects Brazilian coronavirus variant in resident amid spike in cases
Michigan health officials on Thursday reported the first known case of the Brazilian coronavirus variant in the state. The variant, identified as P.1, was detected by commercial lab Quest in a Bay County resident. Officials said contact tracing was underway and that they are reviewing the individual’s travel history in an attempt to identify a potential source. The discovery marks the second variant detected among residents in the states, as three additional cases involving the B.1.1.7 strain are also being investigated.
As the coronavirus has spread around the world, it has constantly mutated, leading to the emergence of new strains. The variant of the SARS-Cov-2 virus first discovered in South Africa late last year is among those most concerning health experts.
The South African variant
The South African variant, also known as B.1.351, was first discovered late last year. It has since been detected in dozens of countries around the world.
How dangerous is India’s ‘double mutant’ COVID-19 variant?
Dr Khan examines what we know so far about the new variant.I have written extensively about variants originating in the United Kingdom, Brazil, South Africa and New York; this week, it is the turn of India.
It contains two mutations that have raised concerns that it could be more infectious than previous strains of the virus and could be able to evade some of the antibody response caused by vaccines or previous infections.
The first, known as the N501Y mutation, makes it more likely to bind to human cells, which could enhance its transmissibility. It also has the E484K mutation, which is thought to help the virus evade parts of the immune system and antibodies.
According to the, preliminary studies suggested the variant was associated with “a higher viral load, which may suggest potential for increased transmissibility, this, as well as other factors that influence transmissibility, are subject of further investigation”.
Surface Laptop 4: Data and Prices Jellact
This month, Microsoft will launch the new Surface 4 laptops. What you will cost and from when you are available. © WinFuture Marketing Render Image of the Surface 4 Laptop of Microsoft. most recently Microsoft had a update in autumn 2019 and also introduced two different sizes - 13.5 and 15 inches. The successor model Surface Laptop 4 now seems to be immediately in the starting blocks.
“Moreover, at this stage, there is no clear evidence of the new variant being associated with more severe disease or worse outcomes,” the WHO said.
Do vaccines work against the variant?
A real-world study released in Israel on Saturday found that the variant first discovered in South Africa can “break through” Pfizer-BioNTech’s coronavirus vaccine to some extent.
The study compared almost 400 people who had tested positive for COVID-19, 14 days or more after they received one or two doses of the vaccine, against the same number of unvaccinated patients with the disease. It matched age and gender, among other characteristics.
The South African variant was found to make up about one percent of all the COVID-19 cases across all the people studied, according to the study by Tel Aviv University and Israel’s largest healthcare provider, Clalit.
But among patients who had received two doses of the vaccine, the variant’s prevalence rate was eight times higher than those unvaccinated – 5.4 percent versus 0.7 percent.
Canada: What is known about the largest cluster in the world with the Brazilian Variant
with 877 confirmed cases, British Columbia has become the center of the largest number of contagions in the Brazilian variant, outside Brazil.
This suggests the vaccine is less effective against the South African variant, compared with the original coronavirus and a variant first identified in Britain that has come to comprise nearly all COVID-19 cases in Israel, the researchers said.
“We found a disproportionately higher rate of the South African variant among people vaccinated with a second dose, compared to the unvaccinated group. This means that the South African variant is able, to some extent, to break through the vaccine’s protection,” said Tel Aviv University’s Adi Stern.
The researchers cautioned that the study only had a small sample size of people infected with the South African variant because of its rarity in Israel.
They also said the research was not intended to deduce overall vaccine effectiveness against any variant, since it only looked at people who had already tested positive for COVID-19, not at overall infection rates.
Pfizer made no immediate comment on the Israeli study, which has not been peer-reviewed.
Earlier this month, Pfizer and BioNTech said clinical trial data signalled that their COVID-19 vaccine could protect against B.1.351. In a trial with some 800 participants in South Africa, a relatively small number, the companies found that the shot was 100 percent effective in preventing illness.
Some previous studies have indicated that the Pfizer-BioNTech shot was less effective against the B.1.351 variant than against other variants of the coronavirus, but still offered a robust defence.
As for the Moderna vaccine, the company producing it said in late January that its vaccine was effective against the South African strain.
While there was a six-fold reduction in neutralising antibodies produced against the South African variant, the levels remained above those that are expected to be protective, Moderna said.
Meanwhile, the Oxford-AstraZeneca vaccine offers as little as 10 percent protection against the variant, researchers have suggested.
A trial of Johnson & Johnson’s vaccine, which was made in partnership with Janssen Pharmaceuticals, found it was about 85 percent effective in protecting against severe cases of COVID-19, and 57 percent effective against all forms of the disease.
Indian COVID-19 variant could 'scupper' easing of lockdown rules, warns expert .
The Indian coronavirus mutation could "scupper" the UK's march to freedom, a leading scientist has warned. © Reuters People swab themselves for coronavirus at a testing site on Clapham Common in London It comes despite the lockdown and vaccine programme leading to cases falling to a seven-month low.COVID-19 infections across the UK dropped to the lowest level since the autumn, according to the latest figures.But a professor of immunology has said the country should be on its guard against a third wave of coronavirus after 77 cases of the B.1.